[1]
Zeppola, T. 2018. Efficacy of second-line treatment with capecitabine and lapatinib in HER2-positive mammary neoplasia, with encephalic metastasis, after first-line therapy with dual anti-HER2 block: Efficacia in II linea del trattamento con capecitabina e lapatinib nella neoplasia mammaria HER2-positiva, con metastasi encefaliche, dopo I linea con do . AboutOpen. 4, 1 (Jun. 2018), 62–65. DOI:https://doi.org/10.19156/abtpn.2018.0043.